HealthTell has numerous relationships with major biopharmaceutical firms to facilitate clinical drug development.
HealthTell’s ImmunoSignature libraries provide the capability to monitor a person’s humoral immune response by providing binding events indicative of both active immune system physiology and memory.
ImmunoSignatures are accessible in many sample types and aid in biopharmaceutical trials by: informing patient selection, predicting response to therapeutics and indicating possible adverse events.
Biopharmaceutical firms include HelathTell ImmunoSignature measurements as part of their clinical trial, starting as early as phase I- phase 4. Analysis of samples will be available in days or, as specified by clinical protocols.
To learn more about how to partner with HealthTell, contact us!